Douglas Treco

2023

In 2023, Douglas Treco earned a total compensation of $5.3M as Chief Executive Officer at Inozyme Pharma.

Compensation breakdown

Bonus$7,500
Non-Equity Incentive Plan$200,000
Option Awards$4,134,601
Salary$375,000
Stock Awards$573,000
Other$9,375
Total$5,299,476

Treco received $4.1M in option awards, accounting for 78% of the total pay in 2023.

Treco also received $7.5K in bonus, $200K in non-equity incentive plan, $375K in salary, $573K in stock awards and $9.4K in other compensation.

Rankings

In 2023, Douglas Treco's compensation ranked 105th out of 2,821 executives tracked by ExecPay. In other words, Treco earned more than 96.3% of executives.

ClassificationRankingPercentile
All
105
out of 2,821
96th
Division
Manufacturing
58
out of 1,551
96th
Major group
Chemicals And Allied Products
35
out of 877
96th
Industry group
Drugs
34
out of 840
96th
Industry
Pharmaceutical Preparations
23
out of 605
96th
Source: SEC filing on April 26, 2024.

Treco's colleagues

We found three more compensation records of executives who worked with Douglas Treco at Inozyme Pharma in 2023.

2023

Axel Bolte

Inozyme Pharma

Chief Executive Officer

2023

Matthew Winton

Inozyme Pharma

Chief Operating Officer

2023

Sanjay Subramanian

Inozyme Pharma

Chief Financial Officer

News

In-depth

You may also like